Clinical and biological significance of
Adult
Aged
Antineoplastic Agents
/ pharmacology
Apoptosis
Biomarkers, Tumor
/ genetics
Case-Control Studies
Cell Movement
Cell Proliferation
Cisplatin
/ pharmacology
Endometrial Neoplasms
/ drug therapy
Enhancer of Zeste Homolog 2 Protein
/ antagonists & inhibitors
Female
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Neoplasm Recurrence, Local
/ drug therapy
Prognosis
RNA, Small Interfering
/ genetics
Survival Rate
Tumor Cells, Cultured
EZH2
endometrial cancer
nanoparticle
peroxiredoxin 6
siRNA
Journal
Cancer biology & therapy
ISSN: 1555-8576
Titre abrégé: Cancer Biol Ther
Pays: United States
ID NLM: 101137842
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
24
10
2019
medline:
30
3
2021
entrez:
24
10
2019
Statut:
ppublish
Résumé
The objective of this study was to examine the clinical significance of
Identifiants
pubmed: 31640461
doi: 10.1080/15384047.2019.1672455
pmc: PMC7012102
doi:
Substances chimiques
Antineoplastic Agents
0
Biomarkers, Tumor
0
RNA, Small Interfering
0
EZH2 protein, human
EC 2.1.1.43
Enhancer of Zeste Homolog 2 Protein
EC 2.1.1.43
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
147-156Références
Int J Cancer. 2009 Mar 1;124(5):1045-53
pubmed: 19058181
J Biol Chem. 2003 Jul 4;278(27):25179-90
pubmed: 12732627
Free Radic Biol Med. 2005 Jun 15;38(12):1543-52
pubmed: 15917183
J Biol Chem. 2000 Sep 15;275(37):28421-7
pubmed: 10893423
Clin Cancer Res. 2006 Feb 15;12(4):1168-74
pubmed: 16489070
Cancer Cell. 2010 Aug 9;18(2):185-97
pubmed: 20708159
Clin Cancer Res. 2014 May 15;20(10):2740-50
pubmed: 24634380
J Breast Cancer. 2018 Sep;21(3):288-296
pubmed: 30275857
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
pubmed: 9843981
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11599-604
pubmed: 12193653
Cancer Res. 2005 Aug 1;65(15):6910-8
pubmed: 16061675
Clin Cancer Res. 2010 Aug 1;16(15):3910-22
pubmed: 20538762
Clin Adv Hematol Oncol. 2006 Jun;4(6):459-68
pubmed: 16981669
Cold Spring Harb Protoc. 2016 Aug 01;2016(8):
pubmed: 27480717
Ann Oncol. 2007 Mar;18(3):409-20
pubmed: 17150999
Cancer Sci. 2006 Jun;97(6):484-91
pubmed: 16734726
Curr Opin Genet Dev. 2002 Apr;12(2):210-8
pubmed: 11893495
J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205
pubmed: 19641174
Nature. 2002 Oct 10;419(6907):624-9
pubmed: 12374981
Clin Cancer Res. 2009 Jun 1;15(11):3770-80
pubmed: 19470734
Proteomics. 2006 Jun;6(11):3352-68
pubmed: 16637015
Cancer Biol Ther. 2009 Jun;8(11):1027-34
pubmed: 19395869
Gynecol Oncol. 2013 Feb;128(2):344-8
pubmed: 22871469
Cell Death Differ. 2011 Mar;18(3):405-14
pubmed: 20829884
Oncogene. 2009 Oct 8;28(40):3551-62
pubmed: 19668227
Cancer Invest. 2011 Jan;29(1):21-8
pubmed: 21166495
Int J Mol Med. 2005 Aug;16(2):349-53
pubmed: 16012774
PLoS One. 2011 Mar 07;6(3):e14750
pubmed: 21408099
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Br J Cancer. 2011 Apr 12;104(8):1278-87
pubmed: 21487429